memantine drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| memantine | associated_with | AD patients | — | 1 |
| memantine | associated_with | Alzheimer's disease | — | 1 |
Mentioned in (11)
Papers in which this entity is mentioned.
- A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. (2021)
- Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study. (2015)
- Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats. (2014)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss. (2011)
- Fetal alcohol spectrum disorders: experimental treatments and strategies for intervention. (2011)
- Fetal alcohol spectrum disorders: research challenges and opportunities. (2011)
- The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. (2011)
- Down syndrome--recent progress and future prospects. (2009)
- Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. (2009)
- Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| memantine | drug | 11 | 123 |